Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Craft

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2015
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trialHenk van den Berg, Michael Paulussen, Gwénaël Le Teuff, et al.
Nature Genetics|October 7, 2008
Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumorRichard H Scott, Jenny Douglas, Linda Baskcomb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2018
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008Jeremy Whelan, Marie-Cecile Le Deley, Uta Dirksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008Uta Dirksen, Bernadette Brennan, Marie-Cécile Le Deley, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2015
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trialHenk van den Berg, Michael Paulussen, Gwénaël Le Teuff, et al.
Nature Genetics|October 7, 2008
Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumorRichard H Scott, Jenny Douglas, Linda Baskcomb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2018
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008Jeremy Whelan, Marie-Cecile Le Deley, Uta Dirksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008Uta Dirksen, Bernadette Brennan, Marie-Cécile Le Deley, et al.
Pageof 3